The purpose of this new training grant is to create a cadre of pathology- oriented medical scientists grounded in molecular, pathobiologic, and clinical aspects of cancer. In order to meet a shortage of scientists trained in the pathobiology of cancer, the Program proposes to phase in ten training slots divided equally among M.D. and Ph.D. scientists. Upon completion of the Program, such academic scientists will be capable not only of fundamental mechanistic and pathogenetic studies, but also of translational research programs which may bridge the gap between basic science and new approaches to diagnosis and therapy. Program resources will be considerably leveraged by the substantial commitment of Johns Hopkins and the Department of Pathology to the training of cancer- oriented academic medical scientists. Regardless of their degree, effective scientists in cancer research need to combine a realistic knowledge of cancer and specific neoplasms with state-of-the-art research skills. The Program proposes core training for all trainees consisting of: [1] intensive research training of up to three years in the laboratory of one of the training faculty; [2] ongoing participation in major Departmental conferences and a journal club; and [3] ongoing participation in a multidisciplinary clinical conference related to research interests. Required additional enhancements designed for Ph.D. trainees but available to all include: [4] a molecularly- focused course in Pathobiology; [5] brief clinical rotations in Oncology and Surgical Oncology; [6] instruction in basic histopathology of cancer; and [7] instruction in basic Laboratory Medicine aspects of cancer. The Program is designed to fill a unique training niche and to enhance existing training programs in cancer at Johns Hopkins without overlap. The twenty-five training faculty members include preceptors skilled in cancer-oriented molecular biology & genetics, biochemistry, cell biology, and immunology. Clinical specialties of Pathology, Oncology, Surgical Oncology, and Comparative Medicine are represented. Formulated in consultation with existing programs, the Program proposes to initiate a Council of Cancer-oriented Training Programs to promote sharing of resources among programs, to enhance training in all programs, and to eliminate duplications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA067751-04
Application #
2895293
Study Section
Cancer Research Manpower and Education Review Committee (CRME)
Program Officer
Eckstein, David J
Project Start
1996-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Pathology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Jhaveri, Teraneh Z; Woo, Juhyung; Shang, Xiaobin et al. (2015) AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Oncotarget 6:14754-65
Sfanos, Karen S; Canene-Adams, Kirstie; Hempel, Heidi et al. (2015) Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites. Cancer Prev Res (Phila) 8:683-92
Orr, Brent A; Gallia, Gary L; Dogan, Ahmet et al. (2014) IgA/kappa-restricted crystal storing histiocytosis involving the central nervous system characterized by proteomic analysis. Clin Neuropathol 33:23-8
Canene-Adams, Kirstie; Sfanos, Karen S; Liang, Chung-Tiang et al. (2013) Dietary chemoprevention of PhIP induced carcinogenesis in male Fischer 344 rats with tomato and broccoli. PLoS One 8:e79842
Chu, Qian; Orr, Brent A; Semenkow, Samantha et al. (2013) Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade. Clin Cancer Res 19:3224-33
McDonald, Oliver G; Maitra, Anirban; Hruban, Ralph H (2012) Human correlates of provocative questions in pancreatic pathology. Adv Anat Pathol 19:351-62
Orr, Brent A; Haffner, Michael C; Nelson, William G et al. (2012) Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 7:e41036
Rodriguez, Fausto J; Orr, Brent A; Ligon, Keith L et al. (2012) Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 3:98-106
Orr, Brent A; Eberhart, Charles G (2012) Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature. Am J Pathol 180:1768-71
Heaphy, Christopher M; Subhawong, Andrea Proctor; Gross, Amy L et al. (2011) Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes. Mod Pathol 24:194-200

Showing the most recent 10 out of 33 publications